A research team engineered thymidine auxotrophic and recombination-deficient versions of commonly used and underutilized ...

Genetic modification of mosquitoes with the FREP1Q224 allele shows significant promise for malaria elimination, maintaining ...

Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment - immunotherapy - may help change the environment where cancer cells ...

While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as ...